Creatinine, arsenic metabolism, and renal function in an arsenic-exposed population in Bangladesh

PLoS ONE

Volumn 9, Issue 12, 2014, Pages

  Peters, Brandilyn A ^a   Hall, Megan N ^a   Liu, Xinhua ^a   Neugut, Y Dana ^a   Pilsner, J Richard ^b   Levy, Diane ^a   Ilievski, Vesna ^a   Slavkovich, Vesna ^a   Islam, Tariqul ^c   Factor Litvak, Pam ^a   Graziano, Joseph H ^a   Gamble, Mary V ^a  

^a Department of Environmental Health Sciences Mailman School of Public Health Columbia University ^*  (United States)

^b UNIVERSITY OF MASSACHUSETTS   (United States)

^c Och Spine at New York Presbyterian Hospitals   (Bangladesh)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC; ARSENIC ACID; ARSENIC TRIOXIDE; ARSENOBETAINE; ARSENOCHOLINE; BIOLOGICAL MARKER; CREATINE; CREATININE; CYANOCOBALAMIN; CYSTATIN C; DIMETHYLARSINOUS ACID; DRINKING WATER; FOLIC ACID; HOMOCYSTEINE; MONOMETHYLARSONOUS ACID; ORGANOARSENIC DERIVATIVE; S ADENOSYLMETHIONINE; UNCLASSIFIED DRUG; WATER POLLUTANT;

ADULT; ARSENIC URINE LEVEL; ARTICLE; BANGLADESH; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CORRELATIONAL STUDY; CREATININE URINE LEVEL; CROSS-SECTIONAL STUDY; ENVIRONMENTAL EXPOSURE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; METAL METABOLISM; METHYLATION; PREVALENCE; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; SEX DIFFERENCE; TOXICITY TESTING; URINALYSIS; URINARY EXCRETION; URINE LEVEL; WATER ANALYSIS; ADOLESCENT; ADVERSE EFFECTS; CHEMICALLY INDUCED; CHEMISTRY; KIDNEY DISEASE; METABOLISM; MIDDLE AGED; URINE; WATER POLLUTANT; YOUNG ADULT;

ADOLESCENT; ADULT; ARSENIC; BANGLADESH; CREATININE; CROSS-SECTIONAL STUDIES; ENVIRONMENTAL EXPOSURE; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY DISEASES; MALE; MIDDLE AGED; S-ADENOSYLMETHIONINE; WATER POLLUTANTS, CHEMICAL; YOUNG ADULT;

EID: 84914689459     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0113760     Document Type: Article

References (84)

1. Kinniburgh D, Smedley P (2001) Arsenic contamination of groundwater in Bangladesh. Keyworth: British Geological Survey.
2. Van Geen A, Ahsan H, Horneman AH, Dhar RK, Zheng Y, et al. (2002) Promotion of well-switching to mitigate the current arsenic crisis in Bangladesh. Bull World Health Organ 80: 732-737.
3. IARC (2012) A Review of Human Carcinogens: Arsenic, Metals, Fibres, and Dusts. Lyon, France: World Health Organization.
4. Chen Y, Parvez F, Gamble M, Islam T, Ahmed A, et al. (2009) Arsenic exposure at low-to-moderate levels and skin lesions, arsenic metabolism, neurological functions, and biomarkers for respiratory and cardiovascular diseases: review of recent findings from the Health Effects of Arsenic Longitudinal Study (HEALS) in Bangladesh. Toxicol Appl Pharmacol 239: 184-192.
5. Navarro Silvera SA, Rohan TE (2007) Trace elements and cancer risk: a review of the epidemiologic evidence. Cancer Causes Control 18: 7-27.
6. Tseng CH, Chong CK, Tseng CP, Hsueh YM, Chiou HY, et al. (2003) Long-term arsenic exposure and ischemic heart disease in arseniasis-hyperendemic villages in Taiwan. Toxicol Lett 137: 15-21.
7. Wasserman GA, Liu X, Parvez F, Ahsan H, Factor-Litvak P, et al. (2007) Water arsenic exposure and intellectual function in 6-year-old children in Araihazar, Bangladesh. Environ Health Perspect 115: 285-289.
8. Wu F, Molinaro P, Chen Y (2014) Arsenic Exposure and Subclinical Endpoints of Cardiovascular Diseases. Curr Environ Health Rep 1: 148-162.
9. Zheng L, Kuo C-C, Fadrowski J, Agnew J, Weaver V, et al. (2014) Arsenic and Chronic Kidney Disease: A Systematic Review. Current Environmental Health Reports 1: 192-207.
10. Lewis DR, Southwick JW, Ouellet-Hellstrom R, Rench J, Calderon RL (1999) Drinking water arsenic in Utah: A cohort mortality study. Environ Health Perspect 107: 359-365.
11. Meliker JR, Wahl RL, Cameron LL, Nriagu JO (2007) Arsenic in drinking water and cerebrovascular disease, diabetes mellitus, and kidney disease in Michigan: a standardized mortality ratio analysis. Environ Health 6: 4.
12. Tsai SM, Wang TN, Ko YC (1999) Mortality for certain diseases in areas with high levels of arsenic in drinking water. Arch Environ Health 54: 186-193.
13. Smith AH, Marshall G, Liaw J, Yuan Y, Ferreccio C, et al. (2012) Mortality in young adults following in utero and childhood exposure to arsenic in drinking water. Environ Health Perspect 120: 1527-1531.
14. Hsueh YM, Chung CJ, Shiue HS, Chen JB, Chiang SS, et al. (2009) Urinary arsenic species and CKD in a Taiwanese population: a case-control study. Am J Kidney Dis 54: 859-870.
15. Chen J-W, Chen H-Y, Li W-F, Liou S-H, Chen C-J, et al. (2011) The association between total urinary arsenic concentration and renal dysfunction in a community-based population from central Taiwan. Chemosphere 84: 17-24.
16. Bera AK, Rana T, Das S, Bhattacharya D, Pan D, et al. (2011) Mitigation of arsenic-mediated renal oxidative stress in rat by Pleurotus florida lectin. Hum Exp Toxicol 30: 940-951.
17. Sinha M, Manna P, Sil PC (2008) Arjunolic acid attenuates arsenic-induced nephrotoxicity. Pathophysiology 15: 147-156.
18. Prabu SM, Muthumani M (2012) Silibinin ameliorates arsenic induced nephrotoxicity by abrogation of oxidative stress, inflammation and apoptosis in rats. Mol Biol Rep 39: 11201-11216.
19. Mussap M, Plebani M (2004) Biochemistry and Clinical Role of Human Cystatin C. Critical Reviews in Clinical Laboratory Sciences 41: 467-550.
20. Challenger F (1945) Biological Methylation. Chemical Reviews 36: 315-361.
21. Challenger F (2006) Biological Methylation. Advances in Enzymology and Related Areas of Molecular Biology: John Wiley & Sons, Inc. pp. 429-491.
22. Lin S, Shi Q, Nix FB, Styblo M, Beck MA, et al. (2002) A NovelS-Adenosyl-l-methionine:Arsenic(III) Methyltransferase from Rat Liver Cytosol. Journal of Biological Chemistry 277: 10795-10803.
23. Thomas DJ, Li J, Waters SB, Xing W, Adair BM, et al. (2007) Arsenic (+3 Oxidation State) Methyltransferase and the Methylation of Arsenicals. Experimental Biology and Medicine 232: 3-13.
24. Barr DB, Wilder LC, Caudill SP, Gonzalez AJ, Needham LL, et al. (2005) Urinary creatinine concentrations in the U.S. population: implications for urinary biologic monitoring measurements. Environmental health perspectives 113: 192-200.
25. Boeniger MF, Lowry LK, Rosenberg J (1993) Interpretation of urine results used to assess chemical exposure with emphasis on creatinine adjustments: a review. Am Ind Hyg Assoc J 54: 615-627.
26. Pilsner JR, Liu X, Ahsan H, Ilievski V, Slavkovich V, et al. (2009) Folate deficiency, hyperhomocysteinemia, low urinary creatinine, and hypomethylation of leukocyte DNA are risk factors for arsenic-induced skin lesions. Environmental health perspectives 117: 254-260.
27. Ahsan H, Chen Y, Kibriya MG, Slavkovich V, Parvez F, et al. (2007) Arsenic Metabolism, Genetic Susceptibility, and Risk of Premalignant Skin Lesions in Bangladesh. Cancer Epidemiology Biomarkers & Prevention 16: 1270-1278.
28. Gamble MV, Liu X (2005) Urinary creatinine and arsenic metabolism. Environ Health Perspect 113: A442-443.
29. Gamble MV, Liu X, Ahsan H, Pilsner JR, Ilievski V, et al. (2006) Folate and arsenic metabolism: a double-blind, placebo-controlled folic acid-supplementation trial in Bangladesh. Am J Clin Nutr 84: 1093-1101.
30. Gamble MV, Liu X, Ahsan H, Pilsner R, Ilievski V, et al. (2005) Folate, homocysteine, and arsenic metabolism in arsenic-exposed individuals in Bangladesh. Environ Health Perspect 113: 1683-1688.
31. Hall MN, Liu X, Slavkovich V, Ilievski V, Pilsner JR, et al. (2009) Folate, Cobalamin, Cysteine, Homocysteine, and Arsenic Metabolism among Children in Bangladesh. Environ Health Perspect 117: 825-831.
32. Hall MN, Gamble MV (2012) Nutritional manipulation of one-carbon metabolism: effects on arsenic methylation and toxicity. J Toxicol 2012: 595307.
33. Basu A, Mitra S, Chung J, Guha Mazumder DN, Ghosh N, et al. (2011) Creatinine, diet, micronutrients, and arsenic methylation in West Bengal, India. Environ Health Perspect 119: 1308-1313.
34. Nermell B, Lindberg AL, Rahman M, Berglund M, Persson LA, et al. (2008) Urinary arsenic concentration adjustment factors and malnutrition. Environ Res 106: 212-218.
35. Kile ML, Hoffman E, Hsueh YM, Afroz S, Quamruzzaman Q, et al. (2009) Variability in biomarkers of arsenic exposure and metabolism in adults over time. Environ Health Perspect 117: 455-460.
36. Mudd SH, Brosnan JT, Brosnan ME, Jacobs RL, Stabler SP, et al. (2007) Methyl balance and transmethylation fluxes in humans. The American Journal of Clinical Nutrition 85: 19-25.
37. Mudd SH, Poole JR (1975) Labile methyl balances for normal humans on various dietary regimens. Metabolism 24: 721-735.
38. Stead LM, Brosnan JT, Brosnan ME, Vance DE, Jacobs RL (2006) Is it time to reevaluate methyl balance in humans? The American Journal of Clinical Nutrition 83: 5-10.
39. Gamble MV, Hall MN (2012) Relationship of creatinine and nutrition with arsenic metabolism. Environ Health Perspect 120: A145-146.
40. Brosnan JT, da Silva RP, Brosnan ME (2011) The metabolic burden of creatine synthesis. Amino Acids 40: 1325-1331.
41. Levey AS, Perrone RD, Madias NE (1988) Serum creatinine and renal function. Annu Rev Med 39: 465-490.
42. Stead LM, Au KP, Jacobs RL, Brosnan ME, Brosnan JT (2001) Methylation demand and homocysteine metabolism: effects of dietary provision of creatine and guanidinoacetate. Am J Physiol Endocrinol Metab 281: E1095-1100.
43. Ginsburg JM (1967) Effect of metabolic alkalosis and acidosis on renal transport of arsenic. Am J Physiol 212: 1334-1340.
44. Ginsburg JM, Lotspeich WD (1963) Interrelations of arsenate and phosphate transport in the dog kidney. Am J Physiol 205: 707-714.
45. Ginsburg JM (1965) Renal mechanism for excretion and transformation of arsenic in the dog. Am J Physiol 208: 832-840.
46. Gamble MV, Ahsan H, Liu X, Factor-Litvak P, Ilievski V, et al. (2005) Folate and cobalamin deficiencies and hyperhomocysteinemia in Bangladesh. The American Journal of Clinical Nutrition 81: 1372-1377.
47. Ahsan H, Chen Y, Parvez F, Argos M, Hussain AI, et al. (2006) Health Effects of Arsenic Longitudinal Study (HEALS): description of a multidisciplinary epidemiologic investigation. J Expo Sci Environ Epidemiol 16: 191-205.
48. Cheng Z, Zheng Y, Mortlock R, Van Geen A (2004) Rapid multi-element analysis of groundwater by high-resolution inductively coupled plasma mass spectrometry. Anal Bioanal Chem 379: 512-518.
49. Van Geen A, Cheng Z, Seddique AA, Hoque MA, Gelman A, et al. (2005) Reliability of a commercial kit to test groundwater for arsenic in Bangladesh. Environ Sci Technol 39: 299-303.
50. van Geen A, Cheng Z, Jia Q, Seddique AA, Rahman MW, et al. (2007) Monitoring 51 community wells in Araihazar, Bangladesh, for up to 5 years: implications for arsenic mitigation. J Environ Sci Health A Tox Hazard Subst Environ Eng 42: 1729-1740.
51. Nixon DE, Mussmann GV, Eckdahl SJ, Moyer TP (1991) Total arsenic in urine: palladium-persulfate vs nickel as a matrix modifier for graphite furnace atomic absorption spectrophotometry. Clin Chem 37: 1575-1579.
52. Slot C (1965) Plasma creatinine determination. A new and specific Jaffe reaction method. Scand J Clin Lab Invest 17: 381-387.
53. Reuter W, Davidowski L, Neubauer K (2003) Speciation of Five Arsenic Compounds in Urine by HPLC/ICP-MS. Shelton, CT: PerkinElmer, Inc.
54. Inker LA, Schmid CH, Tighiouart H, Eckfeldt JH, Feldman HI, et al. (2012) Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med 367: 20-29.
55. Pfeiffer CM, Caudill SP, Gunter EW, Osterloh J, Sampson EJ (2005) Biochemical indicators of B vitamin status in the US population after folic acid fortification: results from the National Health and Nutrition Examination Survey 1999-2000. Am J Clin Nutr 82: 442-450.
56. Pfeiffer CM, Huff DL, Gunter EW (1999) Rapid and Accurate HPLC Assay for Plasma Total Homocysteine and Cysteine in a Clinical Laboratory Setting. Clinical Chemistry 45: 290-292.
57. Kielstein JT, Salpeter SR, Buckley NS, Cooke JP, Fliser D (2008) Two cardiovascular risk factors in one? Homocysteine and its relation to glomerular filtration rate. A meta-analysis of 41 studies with 27,000 participants. Kidney Blood Press Res 31: 259-267.
58. Styblo M, Drobna Z, Jaspers I, Lin S, Thomas DJ (2002) The role of biomethylation in toxicity and carcinogenicity of arsenic: a research update. Environ Health Perspect 110 Suppl 5: 767-771.
59. Steinmaus C, Yuan Y, Kalman D, Rey OA, Skibola CF, et al. (2010) Individual differences in arsenic metabolism and lung cancer in a case-control study in Cordoba, Argentina. Toxicol Appl Pharmacol 247: 138-145.
60. Poreba R, Gac P, Poreba M, Antonowicz-Juchniewicz J, Andrzejak R (2011) Relation between occupational exposure to lead, cadmium, arsenic and concentration of cystatin C. Toxicology 283: 88-95.
61. Hawkesworth S, Wagatsuma Y, Kippler M, Fulford AJ, Arifeen SE, et al. (2013) Early exposure to toxic metals has a limited effect on blood pressure or kidney function in later childhood, rural Bangladesh. Int J Epidemiol 42: 176-185.
62. Nordberg GF, Jin T, Hong F, Zhang A, Buchet JP, et al. (2005) Biomarkers of cadmium and arsenic interactions. Toxicology and Applied Pharmacology 206: 191-197.
63. Zheng LY, Umans JG, Tellez-Plaza M, Yeh F, Francesconi KA, et al. (2013) Urine arsenic and prevalent albuminuria: evidence from a population-based study. Am J Kidney Dis 61: 385-394.
64. Chen Y, Parvez F, Liu M, Pesola GR, Gamble MV, et al. (2011) Association between arsenic exposure from drinking water and proteinuria: results from the Health Effects of Arsenic Longitudinal Study. International Journal of Epidemiology 40: 828-835.
65. Halatek T, Sinczuk-Walczak H, Rabieh S, Wasowicz W (2009) Association between occupational exposure to arsenic and neurological, respiratory and renal effects. Toxicol Appl Pharmacol 239: 193-199.
66. Eom SY, Lee YC, Yim DH, Lee CH, Kim YD, et al. (2011) Effects of low-level arsenic exposure on urinary N-acetyl-beta-D-glucosaminidase activity. Hum Exp Toxicol 30: 1885-1891.
67. Huda MN, Alam KS, Harun Ur R (2012) Prevalence of chronic kidney disease and its association with risk factors in disadvantageous population. Int J Nephrol 2012: 267329.
68. Zubairi AM, Hussain A (2008) The glomerular filtration rate: comparison of various predictive equations based on serum creatinine with conventional creatinine clearance test in Pakistani population. J Pak Med Assoc 58: 182-185.
69. Kottgen A, Selvin E, Stevens LA, Levey AS, Van Lente F, et al. (2008) Serum cystatin C in the United States: the Third National Health and Nutrition Examination Survey (NHANES III). Am J Kidney Dis 51: 385-394.
70. Swan SK (1997) The search continues-an ideal marker of GFR. Clin Chem 43: 913-914.
71. Wyss M, Kaddurah-Daouk R (2000) Creatine and creatinine metabolism. Physiol Rev 80: 1107-1213.
72. Urakami Y, Kimura N, Okuda M, Inui K (2004) Creatinine transport by basolateral organic cation transporter hOCT2 in the human kidney. Pharm Res 21: 976-981.
73. Ciarimboli G, Lancaster CS, Schlatter E, Franke RM, Sprowl JA, et al. (2012) Proximal tubular secretion of creatinine by organic cation transporter OCT2 in cancer patients. Clin Cancer Res 18: 1101-1108.
74. Brown CD, Sayer R, Windass AS, Haslam IS, De Broe ME, et al. (2008) Characterisation of human tubular cell monolayers as a model of proximal tubular xenobiotic handling. Toxicol Appl Pharmacol 233: 428-438.
75. Liu J, Chen H, Miller DS, Saavedra JE, Keefer LK, et al. (2001) Overexpression of glutathione S-transferase II and multidrug resistance transport proteins is associated with acquired tolerance to inorganic arsenic. Mol Pharmacol 60: 302-309.
76. Liu J, Liu Y, Powell DA, Waalkes MP, Klaassen CD (2002) Multidrug-resistance mdr1a/1b double knockout mice are more sensitive than wild type mice to acute arsenic toxicity, with higher arsenic accumulation in tissues. Toxicology 170: 55-62.
77. Sweeney CJ, Takimoto C, Wood L, Porter JM, Tracewell WG, et al. (2010) A pharmacokinetic and safety study of intravenous arsenic trioxide in adult cancer patients with renal impairment. Cancer Chemother Pharmacol 66: 345-356.
78. Brown MM, Rhyne BC, Goyer RA, Fowler BA (1976) Intracellular effects of chronic arsenic administration on renal proximal tubule cells. Journal of Toxicology and Environmental Health 1: 505-514.
79. Peraza MA, Carter DE, Gandolfi AJ (2003) Toxicity and metabolism of subcytotoxic inorganic arsenic in human renal proximal tubule epithelial cells (HK-2). Cell Biol Toxicol 19: 253-264.
80. Liu J, Liu Y, Habeebu SM, Waalkes MP, Klaassen CD (2000) Chronic combined exposure to cadmium and arsenic exacerbates nephrotoxicity, particularly in metallothionein-I/II null mice. Toxicology 147: 157-166.
81. Tsukamoto H, Parker HR, Gribble DH, Mariassy A, Peoples SA (1983) Nephrotoxicity of sodium arsenate in dogs. Am J Vet Res 44: 2324-2330.
82. Chen Y, Wu F, Liu M, Parvez F, Slavkovich V, et al. (2013) A prospective study of arsenic exposure, arsenic methylation capacity, and risk of cardiovascular disease in Bangladesh. Environmental health perspectives 121: 832-838.
83. Drobna Z, Naranmandura H, Kubachka KM, Edwards BC, Herbin-Davis K, et al. (2009) Disruption of the arsenic (+3 oxidation state) methyltransferase gene in the mouse alters the phenotype for methylation of arsenic and affects distribution and retention of orally administered arsenate. Chem Res Toxicol 22: 1713-1720.
84. Buchet JP, Lauwerys R, Roels H (1981) Comparison of the urinary excretion of arsenic metabolites after a single oral dose of sodium arsenite, monomethylarsonate, or dimethylarsinate in man. Int Arch Occup Environ Health 48: 71-79.